Global Health Limited

NSEI:MEDANTA Stock Report

Market Cap: ₹375.5b

Global Health Past Earnings Performance

Past criteria checks 5/6

Global Health has been growing earnings at an average annual rate of 38.6%, while the Healthcare industry saw earnings growing at 29.7% annually. Revenues have been growing at an average rate of 16.8% per year. Global Health's return on equity is 17%, and it has net margins of 14.3%.

Key information

38.6%

Earnings growth rate

37.7%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate16.8%
Return on equity17.0%
Net Margin14.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?

Apr 12
Do Global Health's (NSE:MEDANTA) Earnings Warrant Your Attention?

Is Global Health (NSE:MEDANTA) A Risky Investment?

Mar 22
Is Global Health (NSE:MEDANTA) A Risky Investment?

Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher

Feb 13
Market Participants Recognise Global Health Limited's (NSE:MEDANTA) Earnings Pushing Shares 32% Higher

There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital

Jan 18
There's Been No Shortage Of Growth Recently For Global Health's (NSE:MEDANTA) Returns On Capital

With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Dec 26
With EPS Growth And More, Global Health (NSE:MEDANTA) Makes An Interesting Case

Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Jun 01
Global Health Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors

Mar 30
Global Health Limited's (NSE:MEDANTA) Earnings Haven't Escaped The Attention Of Investors

Revenue & Expenses Breakdown
Beta

How Global Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:MEDANTA Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2331,6604,5195,1860
30 Sep 2330,2774,0894,8890
30 Jun 2328,4983,6943,7280
31 Mar 2327,0723,2614,2890
31 Dec 2225,1642,4261,3680
30 Jun 2223,0432,1326660
31 Mar 2221,7251,9622,9530
31 Mar 2114,5192884420
31 Mar 2015,1823636520
31 Mar 1914,7826105070
31 Mar 1813,6773297620

Quality Earnings: MEDANTA has high quality earnings.

Growing Profit Margin: MEDANTA's current net profit margins (14.3%) are higher than last year (9.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEDANTA's earnings have grown significantly by 38.6% per year over the past 5 years.

Accelerating Growth: MEDANTA's earnings growth over the past year (86.3%) exceeds its 5-year average (38.6% per year).

Earnings vs Industry: MEDANTA earnings growth over the past year (86.3%) exceeded the Healthcare industry 29.5%.


Return on Equity

High ROE: MEDANTA's Return on Equity (17%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.